Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,874 | -6,466 | -2,248 | -7,186 | -4,957 |
| Depreciation Amortization | 77 | 51 | 26 | 119 | 93 |
| Accounts receivable | 413 | 429 | 217 | -378 | -18 |
| Other Working Capital | 3,178 | 1,426 | -265 | -986 | -1,063 |
| Other Operating Activity | 1,020 | 456 | 183 | 1,108 | 343 |
| Operating Cash Flow | $-7,187 | $-4,104 | $-2,087 | $-7,322 | $-5,601 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,998 | 3,498 | 3,498 | 7,718 | 7,497 |
| Common Stock Repurchased | -204 | N/A | -142 | -329 | -295 |
| Other Financing Activity | 0 | -151 | 0 | 9,642 | 9,642 |
| Financing Cash Flow | $6,793 | $3,346 | $3,355 | $17,031 | $16,844 |
| Exchange Rate Effect | -66 | -31 | -9 | 46 | 81 |
| Beginning Cash Position | 10,792 | 10,792 | 10,792 | 1,037 | 1,037 |
| End Cash Position | 10,333 | 10,004 | 12,052 | 10,792 | 12,362 |
| Net Cash Flow | $-460 | $-789 | $1,260 | $9,755 | $11,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,187 | -4,104 | -2,087 | -7,322 | -5,601 |
| Free Cash Flow | -7,187 | -4,104 | -2,087 | -7,322 | -5,601 |